1986
DOI: 10.1007/bf00180825
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of head twitch response to quipazine in rats by chronic amitriptyline but not fluvoxamine or citalopram

Abstract: Chronic (twice daily/14 days), but not acute, treatment with 10 mg/kg PO amitriptyline reduced the number of quipazine (5 mg/kg)-induced head twitches in rats, measured 2 h (but not 72 h) after the last administration of the drug. Similar treatment with fluvoxamine or citalopram, which are more potent and much more specific serotonin uptake inhibitors than amitriptyline, did not affect the quipazine-induced response. In acute experiments, fluvoxamine (10 mg/kg PO) and citalopram (10 mg/kg PO) potentiated the h… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

1
1
0

Year Published

1989
1989
2013
2013

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(2 citation statements)
references
References 45 publications
1
1
0
Order By: Relevance
“…Along these lines, acute inhibition of serotonin reuptake did not inhibit the specific (DOI-induced) 5-HT2A-related behavior. These results are consistent with reports showing that acute fluvoxamine potentiated 5-HTP-induced head-twitch response (Pawlowski and Melzacka 1986) and failed to modify the number of DOI-induced shakes (Kawakami et al 2005). Nevertheless, SSRIs have been proved to be effective after chronic treatment, where a reduction in 5-HT2 receptor responsivity may have occurred in animal models related to human OCD (Nurnberg et al 1997).…”
Section: Discussionsupporting
confidence: 92%
“…Along these lines, acute inhibition of serotonin reuptake did not inhibit the specific (DOI-induced) 5-HT2A-related behavior. These results are consistent with reports showing that acute fluvoxamine potentiated 5-HTP-induced head-twitch response (Pawlowski and Melzacka 1986) and failed to modify the number of DOI-induced shakes (Kawakami et al 2005). Nevertheless, SSRIs have been proved to be effective after chronic treatment, where a reduction in 5-HT2 receptor responsivity may have occurred in animal models related to human OCD (Nurnberg et al 1997).…”
Section: Discussionsupporting
confidence: 92%
“…The stereotypical behavior is induced by the serotonin precursor 5-HTP via an increase of serotonin levels in the synaptic clefts [28] and the subsequent indirect activation of 5-HT 2A receptors [29]. This response has been reported to be enhanced by acute inhibition of 5-HT reuptake by SSRIs [30]. By contrast, DOI, which has an approximately equal affinity for 5-HT 2A , 5-HT 2B and 5-HT 2C receptors, is considered to induce a head-twitch response by a direct agonistic effect on 5-HT 2A receptors, because a DOI-induced head-twitch response is blocked by selective 5-HT 2A antagonists but not by 5-HT 2B/2C antagonists [29,31] and is not modified by SSRIs [17,31].…”
Section: Discussionmentioning
confidence: 99%